INMUNE BIO INC. Other Commitment
INMUNE BIO INC. (INMB) had Other Commitment of $2.65 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Commitment and Contingencies › Other Commitments › Other Commitment, Fiscal Year Maturity
us-gaap:OtherCommitment · last filed 2026-03-30
- 2025-12-31: Other Commitment $2.65M.
- 2025-09-30: Other Commitment $2.63M.
- 2025-06-30: Other Commitment $2.97M.
| Period end | Other Commitment |
|---|---|
| 2025-12-31 | $2.65M 10-K · filed 2026-03-30 |
| 2025-09-30 | $2.63M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $2.97M 10-Q · filed 2025-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |